Financial reports
10-Q
2024 Q3
Quarterly report
12 Feb 24
10-Q
2024 Q2
Quarterly report
13 Nov 23
10-Q
2024 Q1
Quarterly report
10 Aug 23
10-K
2023 FY
Annual report
22 Jun 23
10-Q
2023 Q3
Quarterly report
9 Feb 23
10-Q
2023 Q2
Quarterly report
8 Nov 22
10-Q
2023 Q1
Quarterly report
11 Aug 22
10-K
2022 FY
Annual report
28 Jun 22
10-Q
2022 Q3
Quarterly report
10 Feb 22
10-Q
2022 Q2
Quarterly report
12 Nov 21
Current reports
8-K
Beyond Air® Announces Pricing of $16.0 Million Registered Direct Offering of Common Stock and Warrants
22 Mar 24
8-K
Departure of Directors or Certain Officers
14 Mar 24
8-K
Entry into a Material Definitive Agreement
1 Mar 24
8-K
Beyond Air® Reports Financial Results
16 Feb 24
8-K
Beyond Air® Reports Financial Results
17 Nov 23
8-K
Beyond Air® and Getz Healthcare Enter Strategic Collaboration to
7 Sep 23
8-K
Beyond Air® Reports Financial Results
14 Aug 23
8-K
Beyond Air® Reports Financial Results
23 Jun 23
8-K
Beyond Air® Secures up to $40 Million Debt Financing
20 Jun 23
8-K
Other Events
24 Mar 23
Registration and prospectus
424B5
Prospectus supplement for primary offering
1 Mar 24
S-8
Registration of securities for employees
20 Dec 23
S-3
Shelf registration
11 Aug 23
D
$1.38 mm in equity / options / securities to be acquired, sold $1.38 mm, 2 investors
28 Jun 23
S-8
Registration of securities for employees
17 Feb 23
424B5
Prospectus supplement for primary offering
4 Feb 22
S-3
Shelf registration
24 Jan 22
S-8
Registration of securities for employees
30 Jun 21
424B5
Prospectus supplement for primary offering
20 May 20
S-8
Registration of securities for employees
13 May 20
Proxies
DEFA14A
Additional proxy soliciting materials
8 Feb 24
DEF 14A
Definitive proxy
26 Jan 24
DEFA14A
Additional proxy soliciting materials
31 Jan 23
DEF 14A
Definitive proxy
27 Jan 23
DEFA14A
Additional proxy soliciting materials
21 Jan 22
DEF 14A
Definitive proxy
21 Jan 22
DEFA14A
Additional proxy soliciting materials
22 Jan 21
DEF 14A
Definitive proxy
22 Jan 21
PRER14A
Preliminary revised proxy
21 Jan 21
PRE 14A
Preliminary proxy
12 Jan 21
Other
EFFECT
Notice of effectiveness
22 Aug 23
UPLOAD
Letter from SEC
17 Aug 23
CORRESP
Correspondence with SEC
17 Aug 23
CT ORDER
Confidential treatment order
22 Sep 22
EFFECT
Notice of effectiveness
2 Feb 22
CORRESP
Correspondence with SEC
28 Jan 22
UPLOAD
Letter from SEC
27 Jan 22
UPLOAD
Letter from SEC
22 Jan 21
CORRESP
Correspondence with SEC
21 Jan 21
UPLOAD
Letter from SEC
21 Jan 21